What happens if someone takes 10mg of oral propranolol (a beta blocker) while using albuterol (a bronchodilator)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Taking 10mg of oral propranolol while using albuterol is not recommended due to the potential for propranolol to block the therapeutic effects of albuterol and worsen breathing problems in patients with asthma or COPD. The combination of these two medications can lead to a reduction in the effectiveness of albuterol, a beta-agonist used to treat conditions like asthma or COPD, as propranolol is a beta-blocker that blocks beta receptors in the body 1. This interaction is particularly concerning for individuals with pre-existing respiratory conditions, as propranolol can also cause bronchospasm in susceptible individuals, further exacerbating breathing difficulties.

When considering the management of patients who require both beta-blockade and bronchodilation, it is essential to weigh the potential benefits and risks of each medication. In some cases, a cardioselective beta-blocker like atenolol or metoprolol may be preferred over non-selective beta-blockers like propranolol, as they are less likely to cause bronchospasm in patients with asthma or COPD 1. However, the decision to use any beta-blocker in patients with respiratory conditions should be made with caution and under the guidance of a healthcare provider.

Key considerations for healthcare providers include:

  • Monitoring patients for signs of bronchospasm or worsened breathing problems when initiating beta-blocker therapy
  • Starting with low doses of beta-blockers and titrating up as needed and tolerated
  • Considering alternative treatments for conditions that do not require beta-blockade
  • Educating patients about the potential risks and benefits of combining beta-blockers with bronchodilators like albuterol.

From the FDA Drug Label

Beta-receptor blocking agents and albuterol inhibit the effect of each other

  • Concomitant use: The use of beta-receptor blocking agents, such as propranolol, and albuterol may inhibit the effect of each other.
  • Clinical decision: If someone takes 10mg of oral propranolol while using albuterol, the effectiveness of albuterol may be reduced due to the inhibitory effect of propranolol on beta-receptors.
  • Key consideration: The interaction between propranolol and albuterol may lead to reduced bronchodilation and potentially worsen asthma symptoms 2

From the Research

Interaction between Propranolol and Albuterol

  • The interaction between oral propranolol and albuterol is not directly addressed in the provided studies.
  • However, studies have investigated the effects of beta-blockers on the response to beta2-agonists like albuterol 3, 4.
  • A study found that the cardio-selective beta1-blocker bisoprolol did not significantly impair the bronchodilator response to salbutamol in people with asthma 3.
  • Another study suggested that atenolol, a beta1-blocker, caused less bronchospasm than metoprolol in hypertensive patients with asthma, and it was concluded that atenolol is the preferred agent when beta blockade is required in patients with asthma 4.
  • Propranolol is a non-selective beta-blocker, which may impair the bronchodilator response to beta2-agonists like albuterol 3.
  • There is also a risk of paradoxical bronchoconstriction after inhaled albuterol, which occurred in 4.4% of patients in one study 5.

Potential Effects of Concomitant Use

  • The concomitant use of oral propranolol and albuterol may lead to impaired bronchodilation or increased risk of bronchospasm.
  • However, the exact effects of this combination are not well-studied, and more research is needed to fully understand the potential interactions 3, 4.
  • It is essential to monitor patients for any adverse effects, such as bronchospasm or decreased lung function, when using beta-blockers and beta2-agonists concomitantly 5.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.